Shi's Center of Orthopedics and Traumatology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, 528 Zhangheng Road, Pudong New Area, Shanghai 201203, China.
Institute of Traumatology & Orthopedics, Shanghai Academy of Traditional Chinese Medicine, Shanghai 201203, China.
Evid Based Complement Alternat Med. 2014;2014:343176. doi: 10.1155/2014/343176. Epub 2014 Jan 14.
Objective. The aim of this study is to systematically evaluate the evidence whether traditional Chinese herbal patches (TCHPs) for osteoarthritis (OA) are effective and safe and analyze their medication patterns. Methods. A systematic literature search was performed using all the possible Medical Subject Headings (MeSH) and keywords from January 1979 to July 2013. Both randomized controlled trials (RCTs) and observational studies were included. Estimated effects were analyzed using mean difference (MD) or relative risk (RR) with 95% confidence intervals (CI) and meta-analysis. Results. 86 kinds of TCHPs were identified. RCTs and controlled clinical trials (CCTs) which were mostly of low quality favored TCHPs for local pain and dysfunction relief. TCHPs, compared with diclofenac ointment, had significant effects on global effectiveness rate (RR = 0.50; 95% CI (0.29, 0.87)). Components of formulae were mainly based on the compounds "Xiao Huo Luo Dan" (Minor collateral-freeing pill) and "Du Huo Ji Sheng Tang" (Angelicae Pubescentis and Loranthi decoction). Ten kinds of adverse events (AEs), mainly consisting of itching and/or local skin rashes, were identified after 3-4 weeks of follow-up. Conclusions. TCHPs have certain evidence in improving global effectiveness rate for OA; however, more rigorous studies are warranted to support their use.
本研究旨在系统评估中药贴片(TCHP)治疗骨关节炎(OA)的有效性和安全性证据,并分析其用药模式。
检索 1979 年 1 月至 2013 年 7 月期间的所有可能的医学主题词(MeSH)和关键词,纳入 TCHP 治疗 OA 的随机对照试验(RCT)和观察性研究。使用均数差(MD)或相对危险度(RR)及其 95%置信区间(CI)进行效应估计,并进行 meta 分析。
共纳入 86 种 TCHP。RCT 和对照临床试验(CCT)多为低质量研究,提示 TCHP 可缓解局部疼痛和功能障碍。与双氯芬酸软膏相比,TCHP 对总有效率的影响有统计学意义(RR=0.50;95%CI:0.290.87)。处方成分主要基于“小活络丹”和“独活寄生汤”。10 种不良事件(AE),主要表现为瘙痒和/或局部皮疹,在 34 周随访后出现。
TCHP 对 OA 患者的总有效率有一定疗效证据,但需要更多高质量的研究来支持其应用。